Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2170756 | Cytokine & Growth Factor Reviews | 2009 | 8 Pages |
Abstract
Bone healing is a predictable process that has a high rate of success. For some patients, and in certain clinical settings, this process can be delayed or completely inhibited. This leads to significant morbidity and may also result in time lost from work, costs related to prolonged medical treatment, and continued pain at the site of nonunion or failed spinal fusion. Several growth factors, specifically BMP-2 and BMP-7, have been approved in several countries for specific indications. The use of these products and potential complications of their use are reviewed.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
T. William Axelrad, Thomas A. Einhorn,